Cargando…

Bioinformatics analysis and in vivo validation of ferroptosis-related genes in ischemic stroke

Ischemic stroke (IS) is a neurological condition associated with high mortality and disability rates. Although the molecular mechanisms underlying IS remain unclear, ferroptosis was shown to play an important role in its pathogenesis. Hence, we applied bioinformatics analysis to identify ferroptosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chang, Li, Zhixi, Xi, Hongjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729703/
https://www.ncbi.nlm.nih.gov/pubmed/36506580
http://dx.doi.org/10.3389/fphar.2022.940260
_version_ 1784845526755180544
author Liu, Chang
Li, Zhixi
Xi, Hongjie
author_facet Liu, Chang
Li, Zhixi
Xi, Hongjie
author_sort Liu, Chang
collection PubMed
description Ischemic stroke (IS) is a neurological condition associated with high mortality and disability rates. Although the molecular mechanisms underlying IS remain unclear, ferroptosis was shown to play an important role in its pathogenesis. Hence, we applied bioinformatics analysis to identify ferroptosis-related therapeutic targets in IS. IS-related microarray data from the GSE61616 dataset were downloaded from the Gene Expression Omnibus (GEO) database and intersected with the FerrDb database. In total, 33 differentially expressed genes (DEGs) were obtained and subjected to functional enrichment and protein–protein interaction (PPI) network analyses. Four candidate genes enriched in the HIF-1 signaling pathway (HMOX1, STAT3, CYBB, and TLR4) were selected based on the hierarchical clustering of the PPI dataset. We also downloaded the IR-related GSE35338 dataset and GSE58294 dataset from the GEO database to verify the expression levels of these four genes. ROC monofactor analysis demonstrated a good performance of HMOX1, STAT3, CYBB, and TLR4 in the diagnosis of ischemic stroke. Transcriptional levels of the above four genes, and translational level of GPX4, the central regulator of ferroptosis, were verified in a mouse model of middle cerebral artery occlusion (MCAO)-induced IS by qRT-PCR and western blotting. Considering the regulation of the HIF-1 signaling pathway, dexmedetomidine was applied to the MCAO mice. We found that expression of these four genes and GPX4 in MCAO mice were significantly reduced, while dexmedetomidine reversed these changes. In addition, dexmedetomidine significantly reduced MCAO-induced cell death, improved neurobehavioral deficits, and reduced the serum and brain levels of inflammatory factors (TNF-α and IL-6) and oxidative stress mediators (MDA and GSSG). Further, we constructed an mRNA-miRNA-lncRNA network based on the four candidate genes and predicted possible transcription factors. In conclusion, we identified four ferroptosis-related candidate genes in IS and proposed, for the first time, a possible mechanism for dexmedetomidine-mediated inhibition of ferroptosis during IS. These findings may help design novel therapeutic strategies for the treatment of IS.
format Online
Article
Text
id pubmed-9729703
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97297032022-12-09 Bioinformatics analysis and in vivo validation of ferroptosis-related genes in ischemic stroke Liu, Chang Li, Zhixi Xi, Hongjie Front Pharmacol Pharmacology Ischemic stroke (IS) is a neurological condition associated with high mortality and disability rates. Although the molecular mechanisms underlying IS remain unclear, ferroptosis was shown to play an important role in its pathogenesis. Hence, we applied bioinformatics analysis to identify ferroptosis-related therapeutic targets in IS. IS-related microarray data from the GSE61616 dataset were downloaded from the Gene Expression Omnibus (GEO) database and intersected with the FerrDb database. In total, 33 differentially expressed genes (DEGs) were obtained and subjected to functional enrichment and protein–protein interaction (PPI) network analyses. Four candidate genes enriched in the HIF-1 signaling pathway (HMOX1, STAT3, CYBB, and TLR4) were selected based on the hierarchical clustering of the PPI dataset. We also downloaded the IR-related GSE35338 dataset and GSE58294 dataset from the GEO database to verify the expression levels of these four genes. ROC monofactor analysis demonstrated a good performance of HMOX1, STAT3, CYBB, and TLR4 in the diagnosis of ischemic stroke. Transcriptional levels of the above four genes, and translational level of GPX4, the central regulator of ferroptosis, were verified in a mouse model of middle cerebral artery occlusion (MCAO)-induced IS by qRT-PCR and western blotting. Considering the regulation of the HIF-1 signaling pathway, dexmedetomidine was applied to the MCAO mice. We found that expression of these four genes and GPX4 in MCAO mice were significantly reduced, while dexmedetomidine reversed these changes. In addition, dexmedetomidine significantly reduced MCAO-induced cell death, improved neurobehavioral deficits, and reduced the serum and brain levels of inflammatory factors (TNF-α and IL-6) and oxidative stress mediators (MDA and GSSG). Further, we constructed an mRNA-miRNA-lncRNA network based on the four candidate genes and predicted possible transcription factors. In conclusion, we identified four ferroptosis-related candidate genes in IS and proposed, for the first time, a possible mechanism for dexmedetomidine-mediated inhibition of ferroptosis during IS. These findings may help design novel therapeutic strategies for the treatment of IS. Frontiers Media S.A. 2022-11-24 /pmc/articles/PMC9729703/ /pubmed/36506580 http://dx.doi.org/10.3389/fphar.2022.940260 Text en Copyright © 2022 Liu, Li and Xi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Liu, Chang
Li, Zhixi
Xi, Hongjie
Bioinformatics analysis and in vivo validation of ferroptosis-related genes in ischemic stroke
title Bioinformatics analysis and in vivo validation of ferroptosis-related genes in ischemic stroke
title_full Bioinformatics analysis and in vivo validation of ferroptosis-related genes in ischemic stroke
title_fullStr Bioinformatics analysis and in vivo validation of ferroptosis-related genes in ischemic stroke
title_full_unstemmed Bioinformatics analysis and in vivo validation of ferroptosis-related genes in ischemic stroke
title_short Bioinformatics analysis and in vivo validation of ferroptosis-related genes in ischemic stroke
title_sort bioinformatics analysis and in vivo validation of ferroptosis-related genes in ischemic stroke
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729703/
https://www.ncbi.nlm.nih.gov/pubmed/36506580
http://dx.doi.org/10.3389/fphar.2022.940260
work_keys_str_mv AT liuchang bioinformaticsanalysisandinvivovalidationofferroptosisrelatedgenesinischemicstroke
AT lizhixi bioinformaticsanalysisandinvivovalidationofferroptosisrelatedgenesinischemicstroke
AT xihongjie bioinformaticsanalysisandinvivovalidationofferroptosisrelatedgenesinischemicstroke